Logo image of CRBU

CARIBOU BIOSCIENCES INC (CRBU) Stock Analyst Earnings Estimates

NASDAQ:CRBU - Nasdaq - US1420381089 - Common Stock - Currency: USD

1.31  -0.1 (-7.09%)

After market: 1.33 +0.02 (+1.53%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CRBU revenue by date.CRBU revenue by date.
9.6M
-22.33%
13.85M
44.27%
34.477M
148.93%
10.467M
-69.64%
10.344M
-1.18%
28.74M
177.84%
42.23M
46.94%
270.05M
539.47%
1.548B
473.23%
3.326B
114.86%
651.31M
-80.42%
803.89M
23.43%
EBITDA
YoY % growth
CRBU ebitda by date.CRBU ebitda by date.
-66M
-87.39%
-104.78M
-58.76%
-112.534M
-7.40%
-165.064M
-46.68%
-194.676M
-17.94%
-178.335M
8.39%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CRBU ebit by date.CRBU ebit by date.
-66.98M
-85.44%
-106.4M
-58.85%
-116.059M
-9.08%
-172.436M
-48.58%
-217.544M
-26.16%
-231.687M
-6.50%
-306.954M
-32.49%
-190.615M
37.90%
371.68M
294.99%
1.316B
254.07%
106.76M
-91.89%
247.24M
131.58%
Operating Margin
CRBU operating margin by date.CRBU operating margin by date.
-697.71%-768.23%-336.63%-1,647.42%-2,103.09%-806.15%-726.86%-70.59%24.01%39.57%16.39%30.76%
EPS
YoY % growth
CRBU eps by date.CRBU eps by date.
N/A-1.64
27.45%
-1.45
11.59%
-1.69
-16.64%
-1.94
-14.45%
-2.14
-10.42%
-2.80
-30.99%
-0.64
77.23%
8.77
1,476.00%
25.19
187.21%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.43
-9.93%
-0.45
2.43%
-0.46
-9.29%
-0.49
-28.84%
-0.52
-21.33%
Revenue
Q2Q % growth
2.148M
-39.63%
2.805M
15.48%
2.805M
-19.02%
3.315M
63.78%
3.315M
54.33%
EBITDA
Q2Q % growth
-42.429M
-25.10%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-43.422M
-15.97%
-47.94M
-4.21%
-52.02M
-19.58%
-61.2M
-60.05%
-66.3M
-52.69%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.38
-216.67%
-0.460.0817.12%
Q2 2024
Q2Q % growth
-0.42
12.50%
-0.470.0510.10%
Q1 2024
Q2Q % growth
-0.46 -0.40-0.06-13.88%
Q4 2023
Q2Q % growth
-0.39
11.36%
-0.37-0.02-4.02%
Q3 2023
Q2Q % growth
-0.12
72.73%
-0.420.3071.73%
Q2 2023
Q2Q % growth
-0.48
-9.09%
-0.500.024.90%
Q1 2023
Q2Q % growth
-0.46
-43.75%
-0.500.047.43%
Q4 2022
Q2Q % growth
-0.44
-41.94%
-0.470.036.53%
Q3 2022
Q2Q % growth
-0.44
4.35%
-0.490.0510.69%
Q2 2022
Q2Q % growth
-0.44
71.61%
-0.37-0.07-18.78%
Q1 2022
Q2Q % growth
-0.32 -0.350.039.20%
Q4 2021
Q2Q % growth
-0.31 -0.360.0515.03%
Q3 2021
Q2Q % growth
-0.46 -0.12-0.34-272.71%
Q2 2021
Q2Q % growth
-1.55 0.43-1.98-460.10%
CRBU Yearly EPS VS EstimatesCRBU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15 20 25
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
2.024M
-91.45%
3.159M-1.135M-35.93%
Q2 2024
Q2Q % growth
3.464M
-7.75%
3.099M365K11.78%
Q1 2024
Q2Q % growth
2.429M
-30.64%
2.958M-529K-17.88%
Q4 2023
Q2Q % growth
3.558M
-3.58%
4.706M-1.148M-24.39%
Q3 2023
Q2Q % growth
23.662M
617.03%
3.213M20.449M636.45%
Q2 2023
Q2Q % growth
3.755M
-10.38%
3.129M626K20.01%
Q1 2023
Q2Q % growth
3.502M
31.65%
3.213M289K8.99%
Q4 2022
Q2Q % growth
3.69M
44.14%
3.129M561K17.93%
Q3 2022
Q2Q % growth
3.3M
-17.09%
3.774M-474K-12.56%
Q2 2022
Q2Q % growth
4.19M
183.11%
2.917M1.273M43.64%
Q1 2022
Q2Q % growth
2.66M
67.30%
3.264M-604K-18.50%
Q4 2021
Q2Q % growth
2.56M
161.22%
4.268M-1.708M-40.02%
Q3 2021
Q2Q % growth
3.98M
231.67%
16.83M-12.85M-76.35%
Q2 2021
Q2Q % growth
1.48M
-82.55%
16.83M-15.35M-91.21%
Q1 2021
Q2Q % growth
1.59M
-6.47%
%
CRBU Yearly Revenue VS EstimatesCRBU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 8.12% 0% 5.99%
Revenue0% -27.6% 0% -10.12%